ArticleCancer chemotherapy and pharmacology2024

Evaluation of ABT-751, a novel anti-mitotic agent able to overcome multi-drug resistance, in melanoma cells.

Thamir M Mahgoub et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.